Canada -
English -
Health Canada
onbrez breezhaler capsule
novartis pharmaceuticals canada inc - indacaterol (indacaterol maleate) - capsule - 75mcg - indacaterol (indacaterol maleate) 75mcg - selective beta 2-adrenergic agonists
European Union -
English -
myHealthbox
ultibro breezhaler 85 micrograms/43 micrograms, inhalation powder hard capsules
novartis europharm limited - indacaterol, glycopyrronium bromide - inhalation powder, hard capsule - 110 microgram indacaterol and 50 microgram glycopyrronium - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, adrenergics in combination with anticholinergics - indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd)
Malaysia -
English -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
enerzair breezhaler (indacaterol acetate/glycopyrronium bromide/mometasone furoate) 150/50/160mcg inhalation powder hard capsule
novartis corporation (malaysia) sdn. bhd. - glycopyrronium bromide; mometasone furoate; indacaterol acetate -
Malaysia -
English -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
atectura breezhaler (indacaterol acetate/mometasone furoate) 150/80mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -
Malaysia -
English -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
atectura breezhaler (indacaterol acetate/mometasone furoate) 150/160mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -
Malaysia -
English -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
atectura breezhaler (indacaterol acetate/mometasone furoate) 150/320mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -
Malaysia -
English -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
atectura breezhaler (indacaterol acetatemometasone furoate) 15080mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -
Malaysia -
English -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
atectura breezhaler (indacaterol acetatemometasone furoate) 150160mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -
Malaysia -
English -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
atectura breezhaler (indacaterol acetatemometasone furoate) 150320mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -
New Zealand -
English -
Medsafe (Medicines Safety Authority)
ultibro breezhaler 110/50
novartis new zealand ltd - glycopyrronium bromide 63ug equivalent to glycopyrronium 50 mcg; ; indacaterol maleate 143ug equivalent to indacaterol 110 mcg; - powder filled inhalation capsule - 110/50mcg - active: glycopyrronium bromide 63ug equivalent to glycopyrronium 50 mcg indacaterol maleate 143ug equivalent to indacaterol 110 mcg excipient: carrageenan hypromellose lactose monohydrate magnesium stearate potassium chloride purified water tartrazine - ultibro breezhaler 110/50 is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in patients with chronic obstructive pulmonary disease (copd), and for the reduction of exacerbations of copd in patients with a history of exacerbations.